Search clinical trials for: Atezolizumab Trastuzumab Vinorelbine
Total 2259 results
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruiting
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsTerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
National Cancer Institute, NaplesCompletedMetastatic Breast Cancer
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Fudan UniversityNot yet recruiting
-
Base Therapeutics (Shanghai) Co., Ltd.Shanghai 10th People's HospitalEnrolling by invitation
-
Henan Cancer HospitalUnknown
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Denmark, Germany, Spain, Italy, Brazil
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La RocheUnknown
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Breast CancerItaly
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Susan G. Komen Breast Cancer FoundationTerminated
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Boehringer IngelheimCompletedBreast NeoplasmsKorea, Republic of, Spain, Canada, Germany, Singapore, China, United Kingdom, Taiwan, Israel, United States, Australia, Slovenia, Italy, Brazil, India, Czechia, Netherlands, Ireland, Poland, Belarus, Belgium, Portugal, Russian Federation and more
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Hoffmann-La RocheCompletedBreast CancerCanada, Spain, France, United Kingdom, Italy
-
PfizerCompleted
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Completed
-
West German Study GroupMerck Sharp & Dohme LLC; NanoString Technologies, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Susan G. Komen Breast Cancer FoundationCompleted
-
Dartmouth-Hitchcock Medical CenterAmgenTerminated
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
Harold J. Burstein, MD, PhDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast CancerUnited States
-
University Hospital, BrestRoche Farma, S.A; Pierre Fabre Medicament; Groupe Français de Pneumo-CancérologieCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Eric Winer, MDMassachusetts General Hospital; Yale University; Dana-Farber Cancer Institute; Beth... and other collaboratorsCompletedBreast CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedMetastatic Breast CancerFrance, Switzerland, Netherlands, Germany
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Henan Cancer HospitalRecruiting
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisHoffmann-La RocheRecruiting
-
Vejle HospitalCompletedBreast CancerDenmark
-
SCRI Development Innovations, LLCGlaxoSmithKline; Aventis PharmaceuticalsCompleted
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | PyrotinibChina
-
Incyte CorporationTerminated
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Ludwig-Maximilians - University of MunichPierre Fabre LaboratoriesCompletedCarcinoma Breast Stage IVGermany
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruiting
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingBreast Ductal Carcinoma In SituUnited States, Canada, Puerto Rico, Korea, Republic of
-
Adrienne G. WaksJohns Hopkins University; Pfizer; Breast Cancer Research FoundationActive, not recruiting
-
QLT Inc.TerminatedStage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
-
First Affiliated Hospital of Zhejiang UniversityHoffmann-La Roche; Geneplus-Beijing Co. Ltd.UnknownNon-Small Cell Lung CancerChina